Please login to the form below
Risky Business
Tips to keep protect your Brand Channel on YouTube
Tips to keep protect your Brand Channel on YouTube
- 'Share' can't be disabled, turn embedding off so users can't share content outside of your Brand Channel.
- Be aware of the implications of comments on your Brand Channel.
- If you do decide to moderate comments, make sure you tell your users.
12th November 2012
Share
Related Hub content
Featured jobs
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Account Manager
-
Competitive salary commensurate with experience
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- MaxCyte gets green light for solid tumour cell therapy
- Brexit rebels win vote on European Medicines Agency alignment
- Positive mid-stage trial gives Allergy’s investors some welcome relief
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
- Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
- Ashfield Meetings & Events welcomes largest intake of students in seventh year of undergraduate placement scheme
- AstraZeneca joins Merck in Brexit stockpiling effort
PMHub
Frontera Group
Welcome to Frontera Group where our agencies immerse you into the world of the patient....
Quick links
Infographics
